Nucleolar Protein Treacle Is Important for the Efficient Growth of Mumps Virus.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
12 10 2022
Historique:
pubmed: 23 9 2022
medline: 15 10 2022
entrez: 22 9 2022
Statut: ppublish

Résumé

The nucleolus is the largest structure in the nucleus, and it plays roles in mediating cellular stress responses and regulating cell proliferation, as well as in ribosome biosynthesis. The nucleolus is composed of a variety of nucleolar factors that interact with each other in a complex manner to enable its function. Many viral proteins interact with nucleolar factors as well, affecting cellular morphology and function. Here, to investigate the association between mumps virus (MuV) infection and the nucleolus, we evaluated the necessity of nucleolar factors for MuV proliferation by performing a knockdown of these factors with small interfering (si)RNAs. Our results reveal that suppressing the expression of Treacle, which is required for ribosome biosynthesis, reduced the proliferative potential of MuV. Additionally, the one-step growth kinetics results indicate that Treacle knockdown did not affect the viral RNA and protein synthesis of MuV, but it did impair the production of infectious virus particles. Viral matrix protein (M) was considered a candidate Treacle interaction partner because it functions in the process of particle formation in the viral life cycle and is partially localized in the nucleolus. Our data confirm that MuV M can interact with Treacle and colocalize with it in the nucleolus. Furthermore, we found that viral infection induces relocalization of Treacle in the nucleus. Together, these findings suggest that interaction with Treacle in the nucleolus is important for the M protein to exert its functions late in the MuV life cycle.

Identifiants

pubmed: 36135364
doi: 10.1128/jvi.00722-22
pmc: PMC9555161
doi:

Substances chimiques

Nuclear Proteins 0
Phosphoproteins 0
RNA Precursors 0
RNA, Viral 0
TCOF1 protein, human 0
Viral Matrix Proteins 0
matrix protein, mumps virus 156289-05-3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0072222

Références

PLoS Pathog. 2010 Nov 11;6(11):e1001186
pubmed: 21085610
Int J Biochem Cell Biol. 2010 Sep;42(9):1416-29
pubmed: 20398786
Mol Cell. 2019 Dec 5;76(5):767-783.e11
pubmed: 31540874
J Virol. 2005 Nov;79(22):14346-54
pubmed: 16254369
J Pathol. 2015 Jan;235(2):242-52
pubmed: 25229387
J Virol. 2007 Jul;81(13):6827-36
pubmed: 17442724
J Mol Biol. 2001 Aug 3;311(1):41-55
pubmed: 11469856
Virology. 2011 Apr 10;412(2):341-8
pubmed: 21316727
J Virol. 2006 Nov;80(22):11062-73
pubmed: 16971425
Cell Microbiol. 2011 Jun;13(6):806-13
pubmed: 21501365
J Virol. 2010 May;84(9):4810-5
pubmed: 20147409
J Virol. 2001 May;75(9):4399-401
pubmed: 11287589
J Virol. 2006 Dec;80(24):12070-8
pubmed: 17005661
Nat Rev Mol Cell Biol. 2007 Jul;8(7):574-85
pubmed: 17519961
Cell. 1988 Oct 21;55(2):255-65
pubmed: 3167982
Biochem Biophys Res Commun. 2008 May 2;369(2):287-91
pubmed: 18243139
Virology. 1993 Aug;195(2):596-607
pubmed: 8337834
J Gen Virol. 2007 Apr;88(Pt 4):1243-1250
pubmed: 17374768
Nat Commun. 2016 Jun 29;7:12090
pubmed: 27354316
Virology. 2007 Jul 5;363(2):397-409
pubmed: 17346762
Cell Microbiol. 2015 Aug;17(8):1108-20
pubmed: 26041433
Nature. 2015 Sep 24;525(7570):523-7
pubmed: 26399832
J Gen Virol. 2019 Dec;100(12):1593-1594
pubmed: 31609197
Mol Biol Cell. 2000 Sep;11(9):3061-71
pubmed: 10982400
J Virol. 2009 Jul;83(14):7261-72
pubmed: 19439476
J Gen Virol. 2009 Jan;90(Pt 1):69-73
pubmed: 19088274
Microbiol Immunol. 1996;40(4):271-5
pubmed: 8709862
J Gen Virol. 2020 Jan;101(1):44-58
pubmed: 31793855
Nat Rev Microbiol. 2007 Feb;5(2):119-27
pubmed: 17224921
J Virol. 2017 Feb 28;91(6):
pubmed: 28053100
J Cell Biol. 1994 Dec;127(6 Pt 2):1799-813
pubmed: 7806561
Hum Mol Genet. 2005 Jul 15;14(14):2035-43
pubmed: 15930015
Arch Virol. 2002 Jun;147(6):1077-89
pubmed: 12111420
J Biol Chem. 2020 Feb 28;295(9):2771-2786
pubmed: 31949044
Virus Res. 2014 May 12;184:71-81
pubmed: 24589707
PLoS Pathog. 2020 Mar 16;16(3):e1008430
pubmed: 32176734
J Virol. 2015 Mar;89(6):3188-99
pubmed: 25552722
Biochim Biophys Acta. 2014 Jun;1842(6):840-7
pubmed: 24378568
J Virol. 1999 Aug;73(8):7035-8
pubmed: 10400805
Nat Rev Mol Cell Biol. 2021 Mar;22(3):165-182
pubmed: 32873929
Mol Cell. 2007 Dec 14;28(5):739-45
pubmed: 18082599
PLoS Pathog. 2016 Feb 25;12(2):e1005390
pubmed: 26915013
Lancet. 2008 Mar 15;371(9616):932-44
pubmed: 18342688
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10709-14
pubmed: 15249688
Orthod Craniofac Res. 2007 May;10(2):88-95
pubmed: 17552945
Virol J. 2007 Jan 04;4:1
pubmed: 17204159
J Virol. 1990 Feb;64(2):700-5
pubmed: 2153236
PLoS Pathog. 2015 Mar 17;11(3):e1004739
pubmed: 25782006
J Virol. 2002 Jul;76(13):6743-9
pubmed: 12050387
PLoS Pathog. 2016 Mar 24;12(3):e1005478
pubmed: 27010548
Oncotarget. 2017 Oct 10;8(55):94519-94527
pubmed: 29212246
Nucleic Acids Res. 2017 Dec 1;45(21):12509-12528
pubmed: 29069457
FEBS Lett. 2016 Aug;590(15):2494-511
pubmed: 27350027
J Virol. 1990 Sep;64(9):4137-45
pubmed: 2166809
Nat Commun. 2018 Aug 3;9(1):3057
pubmed: 30076298
J Biol Chem. 2003 Sep 5;278(36):34309-19
pubmed: 12777385
Nat Commun. 2020 Jan 8;11(1):123
pubmed: 31913317
EMBO J. 1998 Jul 15;17(14):3899-908
pubmed: 9670007
J Virol. 2013 Jan;87(1):489-502
pubmed: 23097442
Virology. 2014 Mar;452-453:212-22
pubmed: 24606698
Virus Res. 2004 Dec;106(2):133-45
pubmed: 15567493
J Virol. 2001 Dec;75(23):11384-91
pubmed: 11689619
Microbiol Immunol. 2006;50(3):225-34
pubmed: 16547420
Nat Cell Biol. 2014 Aug;16(8):792-803
pubmed: 25064736

Auteurs

Aika Wakata (A)

Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.

Hiroshi Katoh (H)

Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.

Fumihiro Kato (F)

Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.

Makoto Takeda (M)

Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH